Correction: Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells

Authors

Publication Details

Journal
PLoS ONE
Published
2025-11-03
DOI
https://doi.org/10.1371/journal.pone.0335701
Primary Topic
Inflammatory mediators and NSAID effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells

Antonella Cusimano, James A. McCubrey, Antonina Azzolina, Melchiorre Cervello et al.
PLoS ONE
Inflammatory mediators and NSAID effects
article

Correction: Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells

Antonella Cusimano, James A. McCubrey, Antonina Azzolina, Melchiorre Cervello, Giuseppe Montalto, Nadia Lampiasi, Dimcho Bachvarov
article en

Abstract

No abstract available for this paper.
PLoS ONEVol. 20(11)
Openalex Percentile: Top 64%
Inflammatory mediators and NSAID effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction: Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells — Antonella Cusimano, James A. McCubrey, et al. · PLoS ONE (2025) | TGRS Research Map | TGRS